Arch Therapeutics Inc

Arch Therapeutics Inc is a development stage biotechnology company. It focuses on developing products which manages surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking and provide other advantages during surgery and trauma care. The company’s primary product candidate, collectively known as the AC5 Devices (AC5), are designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.